IRCT20150713023190N12
The effect of Jollab beverage on fatigue and happiness in patients with multiple sclerosis
Investigation the effect of Jollab beverage on fatigue and happiness in patients with multiple sclerosis referring to the MS Association of Rafsanjan
Rafsanjan University of Medical Sciences·Phase 2/3·Iranian Registry Of Clinical Trial·otherCompleted
Study focus
- Disease/Condition
- Multiple sclerosis
- Study type
- Interventional
- Intervention type
- other
Sponsor & location
- Primary sponsor
- Rafsanjan University of Medical Sciences
- Location
- Iran
Timeline & enrollment
- Phase
- Phase 2/3
- Start date
- Jun 05, 2022
- End date
- N/A
ICD-10 classifications
Multiple sclerosisProgressive systemic sclerosisSystemic sclerosisSystemic sclerosis, unspecifiedDiffuse sclerosis
Data source
- Registry
- Iranian Registry Of Clinical Trial
- Trial ID
- IRCT20150713023190N12
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for IRCT20150713023190N12 through Pure Global AI's free database. This Phase 2/3 trial is sponsored by Rafsanjan University of Medical Sciences and is currently Completed. The study focuses on Multiple sclerosis.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Iranian Registry Of Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.